Yawara Niijima

Maebashi, 3710014, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Dipeptidyl peptidase-4 inhibitors may lower body temperature: A case-control study.

Dipeptidyl peptidase-4 inhibitors may lower body temperature: A case-control study.

Journal: Diabetes & metabolic syndrome

Published: April 09, 2023

Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.

Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: April 25, 2019

Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus.

Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus.

Journal: Journal of health, population, and nutrition

Published: February 21, 2019

Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension: Results From the Randomized, Placebo-Controlled SACRA Study.

Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension: Results From the Randomized, Placebo-Controlled SACRA Study.

Journal: Circulation

Published: December 28, 2018

Dipeptidyl peptidase-4 inhibitors attenuate thyroid-stimulating hormone concentrations.

Dipeptidyl peptidase-4 inhibitors attenuate thyroid-stimulating hormone concentrations.

Journal: Journal of diabetes

Published: December 25, 2018

Metformin administration attenuates dipeptidyl peptidase-4 inhibitor-induced increases in Krebs von den Lungen-6 (KL-6) levels.

Metformin administration attenuates dipeptidyl peptidase-4 inhibitor-induced increases in Krebs von den Lungen-6 (KL-6) levels.

Journal: Journal of diabetes

Published: August 31, 2018

Sodium glucose co-transporter 2 inhibitors successfully attenuated seasonal change of glycated haemoglobin A1c.

Sodium glucose co-transporter 2 inhibitors successfully attenuated seasonal change of glycated haemoglobin A1c.

Journal: Clinical medicine (London, England)

Published: August 03, 2017

Postprandial serum C-peptide level is associated with increased urinary albumin-to-creatinine ratio in patients with type 2 diabetes mellitus.

Postprandial serum C-peptide level is associated with increased urinary albumin-to-creatinine ratio in patients with type 2 diabetes mellitus.

Journal: Clinical nephrology

Published: April 14, 2017

Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.

Drug-induced Liver injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report.

Journal: Annals of hepatology

Published: February 25, 2017

Serum sodium ion level influenced by daily salt intake after administration of sodium-glucose cotransporter 2 inhibitors.

Serum sodium ion level influenced by daily salt intake after administration of sodium-glucose cotransporter 2 inhibitors.

Journal: Nutrition (Burbank, Los Angeles County, Calif.)

Published: February 09, 2017

Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance.

Subcutaneous abdominal adipose tissue is associated with an index of insulin sensitivity/resistance.

Journal: Adipocyte

Published: June 29, 2016

Elevated 1-h post-challenge glucose levels associated with increased arterial stiffness.

Elevated 1-h post-challenge glucose levels associated with increased arterial stiffness.

Journal: Journal of diabetes

Published: May 05, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026